CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune Response.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 29 07 2020
accepted: 26 11 2020
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 16 7 2021
Statut: epublish

Résumé

In transplantation, direct allorecognition is a complex interplay between T-cell receptors (TCR) and HLA molecules and their bound peptides expressed on antigen-presenting cells. In analogy to HLA mismatched hematopoietic stem cell transplantation (HSCT), the TCR CDR3β repertoires of alloreactive cytotoxic CD8

Identifiants

pubmed: 33552048
doi: 10.3389/fimmu.2020.588741
pmc: PMC7856301
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
Tumor Necrosis Factor Receptor Superfamily, Member 9 0
Tumor Necrosis Factor-alpha 0
Interferon-beta 77238-31-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

588741

Informations de copyright

Copyright © 2021 Bettens, Calderin Sollet, Buhler and Villard.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Tissue Antigens. 2013 Jun;81(6):414-8
pubmed: 23488546
Trends Immunol. 2015 Nov;36(11):738-749
pubmed: 26508293
PLoS One. 2019 Mar 14;14(3):e0213684
pubmed: 30870493
Biol Blood Marrow Transplant. 2007 Aug;13(8):965-74
pubmed: 17640601
BMC Immunol. 2011 Jul 15;12:39
pubmed: 21762519
Haematologica. 2016 Jun;101(6):680-7
pubmed: 27252513
Lancet Oncol. 2012 Apr;13(4):366-74
pubmed: 22340965
Genome Res. 2011 May;21(5):790-7
pubmed: 21349924
Transpl Immunol. 2014 Mar;30(2-3):59-64
pubmed: 24440708
J Biol Chem. 2014 Jan 10;289(2):628-38
pubmed: 24196962
Lancet Haematol. 2020 Jan;7(1):e50-e60
pubmed: 31669248
Sci Transl Med. 2010 Sep 1;2(47):47ra64
pubmed: 20811043
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5980-5
pubmed: 24711416
JCI Insight. 2018 Aug 9;3(15):
pubmed: 30089728
Cell. 2007 Apr 6;129(1):135-46
pubmed: 17418792
Blood. 2007 Dec 15;110(13):4576-83
pubmed: 17785583
Cell. 2015 Jan 15;160(1-2):37-47
pubmed: 25594173
Blood. 2009 Nov 5;114(19):4099-107
pubmed: 19706884
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
J Clin Invest. 2017 Jun 30;127(7):2473-2481
pubmed: 28628037
Biol Blood Marrow Transplant. 2019 Mar;25(3):417-423
pubmed: 30359734
Front Immunol. 2016 Dec 12;7:584
pubmed: 28018351
Immunol Today. 1998 Sep;19(9):395-404
pubmed: 9745202
Blood. 2014 Dec 18;124(26):3996-4003
pubmed: 25323824
Leukemia. 2010 Jan;24(1):58-65
pubmed: 19924143
Genes Immun. 2014 Apr-May;15(3):176-81
pubmed: 24500399
Lancet. 2003 Apr 5;361(9364):1183-5
pubmed: 12686042
Immunol Cell Biol. 2011 Mar;89(3):388-95
pubmed: 21301478
Haematologica. 2016 Apr;101(4):491-8
pubmed: 26768690
Nucleic Acids Res. 2020 Jan 8;48(D1):D1057-D1062
pubmed: 31588507
PLoS Genet. 2019 Apr 22;15(4):e1008091
pubmed: 31009447
Sci Transl Med. 2013 Nov 13;5(211):211ra157
pubmed: 24225944
Leukemia. 2020 May;34(5):1422-1432
pubmed: 31772297
J Immunol. 2001 Jan 15;166(2):973-81
pubmed: 11145675
Cell. 2014 May 22;157(5):1073-87
pubmed: 24855945
Front Immunol. 2016 Mar 24;7:89
pubmed: 27047489
J Immunol. 2003 Feb 15;170(4):1894-902
pubmed: 12574356
Blood. 2011 Nov 17;118(20):5671-80
pubmed: 21948174
Curr Opin Immunol. 2008 Oct;20(5):588-93
pubmed: 18674615
Nat Genet. 2017 May;49(5):659-665
pubmed: 28369038
J Virol. 2015 Apr;89(8):4517-26
pubmed: 25653453
Curr Transplant Rep. 2016;3(4):275-283
pubmed: 27909647
Haematologica. 2019 Mar;104(3):622-631
pubmed: 30262565
PLoS One. 2014 Nov 03;9(11):e111943
pubmed: 25365040
Front Immunol. 2018 Feb 19;9:280
pubmed: 29520276
Sci Transl Med. 2015 Jan 28;7(272):272ra10
pubmed: 25632034

Auteurs

Florence Bettens (F)

Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Geneva University Hospitals, Geneva, Switzerland.

Zuleika Calderin Sollet (Z)

Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Geneva University Hospitals, Geneva, Switzerland.

Stéphane Buhler (S)

Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Geneva University Hospitals, Geneva, Switzerland.

Jean Villard (J)

Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Geneva University Hospitals, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH